DO analysis showed that 48 potential targets of HS were enriched in CRC, including PTGS2, DPP4, MAPK14, GSK3B, ACHE, CCND1, TNF, BAX, BCL2, CASP3, and CASP8 (Figure S1B). Here, BCL2 is linked to colorectal carcinoma.